12:00 AM
Aug 20, 2012
 |  BC Week In Review  |  Company News  |  Other News

Antigen Discovery infectious, proteomics news

Antigen Discovery received a three-year, Phase II Small Business Innovation Research (SBIR) grant of about $2.5 million from NIH's National Institute of Allergy and Infectious Diseases (NIAID)....

Read the full 114 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >